Stability Comparison of TIVA and Sevoflurane in Prone Spinal Surgery(TIVA:Total Intravenous Anesthesia)
Key facts
- Who runs it
- Saglik Bilimleri Universitesi
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 52 people enrolled
- Started
- 1 May 2023
- Ended
- 30 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Sevoflurane
- TIVA
- Record updated
- 19 August 2024
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- The study included male and female patients aged 18 to 65 years who were scheduled for lumbar spine surgery under general anesthesia. Patients were categorized based on the American Society of Anesthesiologists (ASA) physical status levels I, II, and III
Who cannot take part
- Diagnosis of asthma or chronic obstructive pulmonary disease (COPD)
- Allergies to any drugs
- Severe neurological disorders
- History of sedative or opioid use
- Major cardiac conditions, such as recent myocardial infarction or a left ventricular ejection fraction (EF) less than 55%
- Atrioventricular blocks of second and third degrees
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Key Points:
Read full original descriptionShow less
1. Objective:
o To compare the effects of Total Intravenous Anesthesia (TIVA) and sevoflurane anesthesia on respiratory mechanics, hemodynamic parameters, and neuromonitoring during prone position spinal surgeries. 2. Methodology:
* A randomized controlled trial involving 52 patients scheduled for lumbar spine surgery, randomly assigned to either TIVA or sevoflurane groups. * Respiratory and hemodynamic parameters were measured at various time points. 3. Results:
* No significant differences were found between the TIVA and sevoflurane groups in terms of respiratory mechanics or hemodynamic stability. * Both anesthesia techniques maintained stable intraoperative conditions. 4. Clinical Implications:
* Anesthesiologists can flexibly choose between TIVA and sevoflurane based on patient-specific factors and surgical requirements. * TIVA may be preferred in surgeries with high neurological risk due to its compatibility with neuromonitoring. 5. Future Research:
* Studies with broader patient populations and long-term outcomes are needed to further refine anesthesia management strategies. * Research on the environmental impact and cost-effectiveness of anesthesia techniques is also important.
The 2 groups in the trial
- Sevoflurane GroupExisting treatment, for comparison
In the Sevoflurane group, general anesthesia was maintained with sevoflurane at 0.8-1.0 minimum alveolar concentration (MAC).
Treatment: Sevoflurane
- TIVA groupExisting treatment, for comparison
In the TIVA (Total Intra Venous Anesthesia) group, a combination of propofol (50-150 μg/kg/min) and remifentanil (0.02-0.2 μg/kg/min) was used for general anesthesia instead of inhalational agents.
Treatment: TIVA
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of TIVA and Sevoflurane: Affirming Hemodynamic, Respiratory, and Neuromonitoring Stability in Prone Position Spinal Surgeries
- Record updated
- 19 August 2024